Lmr Partners LLP Allarity Therapeutics, Inc. Call Options Transaction History
Lmr Partners LLP
- $10.9 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ALLR
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About Allarity Therapeutics, Inc.
- Ticker ALLR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,260,200
- Market Cap $14.1M
- Description
- Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...